On the Need for Phase III Studies of Risk-Adapted Therapy in Multiple Myeloma

被引：1
|
作者：
Voorhees, Peter [1 ]
机构：
[1] Carolinas HealthCare Syst, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 02期
关键词：
WORKING GROUP; CONSENSUS;
D O I：
10.1016/j.bbmt.2016.12.622
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [1] Designing risk-adapted therapy for multiple myeloma: The Mayo perspective
    Lonial, Sagar
    [J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (03) : 279 - 281
  • [2] Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
    Dingli, David
    Ailawadhi, Sikander
    Bergsagel, P. Leif
    Buadi, Francis K.
    Dispenzieri, Angela
    Fonseca, Rafael
    Gertz, Morie A.
    Gonsalves, Wilson I.
    Hayman, Susan R.
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Kumar, Shaji K.
    Kyle, Robert A.
    Lacy, Martha Q.
    Leung, Nelson
    Lin, Yi
    Lust, John A.
    Mikhael, Joseph R.
    Reeder, Craig B.
    Roy, Vivek
    Russell, Stephen J.
    Sher, Taimur
    Stewart, A. Keith
    Warsame, Rahma
    Zeldenrust, Stephen R.
    Rajkumar, S. Vincent
    Khan, Asher A. Chanan
    [J]. MAYO CLINIC PROCEEDINGS, 2017, 92 (04) : 578 - 598
  • [3] Risk-adapted treatment in multiple myeloma: Does more make it merrier?
    Zanwar, Saurabh
    Fortuna, Gliceida M. Galarza
    Sborov, Douglas W.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [4] Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
    Barrett, Aisling
    Quinn, John
    Lavin, Michelle
    Thornton, Patrick
    O'Donnell, James
    Murphy, Philip
    Glavey, Siobhan
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [5] Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma
    Hose, Dirk
    Reme, Thierry
    Meissner, Tobias
    Moreaux, Jerome
    Seckinger, Anja
    Lewis, Joe
    Benes, Vladimir
    Benner, Axel
    Hundemer, Michael
    Hielscher, Thomas
    Shaughnessy, John D., Jr.
    Barlogie, Bart
    Neben, Kai
    Kraemer, Alwin
    Hillengass, Jens
    Bertsch, Uta
    Jauch, Anna
    De Vos, John
    Rossi, Jean-Francois
    Moehler, Thomas
    Blake, Jonathon
    Zimmermann, Juergen
    Klein, Bernard
    Goldschmidt, Hartmut
    [J]. BLOOD, 2009, 113 (18) : 4331 - 4340
  • [6] Risk-adapted maintenance therapy (MaintRx) after ASCT in first-line therapy for multiple myeloma (MM)
    Kaufman, Jonathan L.
    Willey, Joanne
    Williams, Michael E.
    Tiscione, Brynn
    Buettner, Arden
    Neely, Douglas
    Green, Mark R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Treatment of newly diagnosed multiple myeloma based on Mayo stratification of myeloma and risk-adapted therapy (mSMART): Consensus statement
    Dispenzieri, Angela
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Fonseca, Rafael
    Lacy, Martha Q.
    Bergsagel, P. Leif
    Kyle, Robert A.
    Greipp, Philip R.
    Witzig, Thomas E.
    Reeder, Craig B.
    Lust, John A.
    Russell, Stephen J.
    Hayman, Suzmnwe R.
    Roy, Vivek
    Kumar, Shaji
    Zeldenrust, Steven R.
    Dalton, Robert J.
    Stewart, A. Keith
    [J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (03) : 323 - 341
  • [8] Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma
    Hose, Dirk
    Reme, Thierry
    Meissner, Tobias
    Moreaux, Jerome
    Seckinger, Anja
    Lewis, Joe
    Benes, Vladimir
    Benner, Axel
    Hundemer, Michael
    Hielscher, Thomas
    Shaughnessy, John D., Jr.
    Barlogie, Bart
    Neben, Kai
    Kraemer, Alwin
    Hillengass, Jens
    Bertsch, Uta
    Jauch, Anna
    De Vos, John
    Rossi, Jean Francois
    Moehler, Thomas
    Blake, Jonathon
    Zimmermann, Juergen
    Klein, Bernard
    Goldschmidt, Hartmut
    [J]. BLOOD, 2008, 112 (11) : 98 - 98
  • [9] Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment
    Cerchione, Claudio
    Usmani, Saad Z.
    Stewart, A. Keith
    Kaiser, Martin
    Rasche, Leo
    Kortuem, Martin
    Mateos, Maria-Victoria
    Spencer, Andrew
    Sonneveld, Pieter
    Anderson, Kenneth C.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
    Kumar, Shaji K.
    Mikhael, Joseph R.
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Fonseca, Rafael
    Gertz, Morie A.
    Greipp, Philip R.
    Hayman, Suzanne R.
    Kyle, Robert A.
    Lacy, Martha Q.
    Lust, John A.
    Reeder, Craig B.
    Roy, Vivek
    Russell, Stephen J.
    Short, Kristen E. Detweiler
    Stewart, A. Keith
    Witzig, Thomas E.
    Zeldenrust, Steven R.
    Dalton, Robert J.
    Rajkumar, S. Vincent
    Bergsagel, P. Leif
    [J]. MAYO CLINIC PROCEEDINGS, 2009, 84 (12) : 1095 - 1110
12345